Evidence map›Paper›PMID 31533002›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

mTORC1 as a cell-intrinsic rheostat that shapes development, preimmune repertoire, and function of B lymphocytes.

Ariel L Raybuck, Keunwook Lee, Sung Hoon Cho, Jingxin Li, James W Thomas, Mark R Boothby

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Activated PIK3CD drives marginal zone B cell development from early transitional progenitors by enhancing ADAM10 expression.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ariel L RaybuckDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Keunwook LeeDepartment of Biomedical Science, Hallym University, Chuncheon, Gangwon-do, South Korea.
Sung Hoon ChoDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jingxin LiDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
James W ThomasDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Mark R BoothbyDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · USHallym University · KR

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Selection &Regulation of B Lymphocytes in IDDMR01AI051448 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BONAMI, RACHEL H · 2003 to 2022
$7.3M
Roles of rictor in mTOR signaling, differentiation & immune memory via Akt & PKCR01HL106812 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOOTHBY, MARK R · 2011 to 2018
$3.1M
Fit to remember? B cell metabolic 'fitness', AMPK & recall antibody responsesR01AI113292 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOOTHBY, MARK R · 2015 to 2019
$1.9M
Fit to remember? B cell metabolic 'fitness', AMPK & recall antibody responsesR56AI113292 · NIAID · VANDERBILT UNIVERSITY · PI BOOTHBY, MARK R · 2014 to 2014
$393k
XFe96 AnalyzerS10OD018015 · OD · VANDERBILT UNIVERSITY · PI LANNIGAN, DEBORAH · 2014 to 2014
$200k
Selection &Regulation of B Lymphocytes in IDDMR21AI051448 · NIAID · VANDERBILT UNIVERSITY · PI THOMAS, JAMES WARD · 2003 to 2003
$138k
NCI NIH HHS P30 CA068485NHLBI NIH HHS R01 HL106812NIAID NIH HHS R01 AI051448NIAID NIH HHS R01 AI113292NIAID NIH HHS R21 AI051448NIAID NIH HHS R56 AI113292NIH HHS S10 OD018015
6 · The paper itself

Abstract

Ample evidence indicates that nutrient concentrations in extracellular milieux affect signaling mediated by environmental sensor proteins. For instance, the mechanistic target of rapamycin (mTOR) is reduced during protein malnutrition and is known to be modulated by concentrations of several amino acids when in a multiprotein signaling complex that contains regulatory-associated protein of mTOR. We hypothesized that a partial decrease in mTOR complex 1 (mTORC1) activity intrinsic to B-lineage cells would perturb lymphocyte development or function, or both. We show that a cell-intrinsic decrease in mTORC1 activity impacted developmental progression, antigen receptor repertoire, and function along the B lineage. Thus, preimmune repertoires of B-lineage cells were altered in the marrow and periphery in a genetic model of regulatory-associated protein of mTOR haplo-insufficiency. An additional role for mTORC1 was revealed when a B-cell antigen receptor transgene was found to circumvent the abnormal B-cell development: haploinsufficient B cells were profoundly impaired in responses to antigen

Indexed as

AnimalsB-LymphocytesEnzyme-Linked Immunosorbent AssayFlow CytometryImmunoblottingMechanistic Target of Rapamycin Complex 1MiceRegulatory-Associated Protein of mTORSignal TransductionMechanistic Target of Rapamycin Complex 1Regulatory-Associated Protein of mTORRptor protein, mouseimmunityprotein malnutritionsignaling

Identifiers

PMID31533002
PMCPMC6894075
OpenAlexW2973660624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.